Know Cancer

or
forgot password

Triple Negative Breast Cancer: Study of Molecular and Genetic Factors


N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

Triple Negative Breast Cancer: Study of Molecular and Genetic Factors


Inclusion Criteria:



- women > 18

- non metastatic breast cancer

- triple negative

- 5 years follow-up

- signed informed consent

Exclusion Criteria:

- other cancer (except in situ)

- metastases at diagnosis

- impossibility of follow-up

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label

Outcome Measure:

incidence of BRCA1/2, PALB2, PTEN, PALB2 mutations

Outcome Description:

1) Determine the incidence of the BRCA1/2, PALB2, PTEN, PALB2 mutations in patients having at diagnosis a non metastatic triple negative breast cancer

Outcome Time Frame:

up to 1 month

Safety Issue:

No

Principal Investigator

Jean-Marc EXTRA, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Institut Paoli-Calmettes

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

SA03/IPC 2010-003

NCT ID:

NCT01434420

Start Date:

March 2011

Completion Date:

March 2019

Related Keywords:

  • Breast Cancer
  • triple negative breast cancer
  • Breast Neoplasms

Name

Location